Your browser doesn't support javascript.
loading
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
Liu, Xia; Li, Xiaomei; Li, Xiangpei; Li, Zhijun; Zhao, Dongbao; Liu, Shengyun; Zhang, Miaojia; Zhang, Fengxiao; Zhu, Ping; Chen, Jinwei; Wei, Wei; Lin, Bing; Zhou, Yingbo; Chen, Jing; Pang, Yafei; Zhang, Lei; Sun, Xiaoxuan; Yu, Zhibo; Jia, Yun; Wang, Jia; Sun, Wenwen; Chiu, Frank; Pang, Liping; Wang, Guochun.
Afiliação
  • Liu X; Department of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China.
  • Li X; Department of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
  • Li X; Department of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
  • Li Z; Department of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
  • Zhao D; Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
  • Liu S; Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang M; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhang F; Department of Rheumatology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Zhu P; Department of Clinical Immunology, Xi-Jing Hospital, Xi'an, Shaanxi, China.
  • Chen J; Division of Rheumatoid Immunology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Wei W; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Lin B; Department of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China.
  • Zhou Y; Department of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
  • Chen J; Department of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
  • Pang Y; Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
  • Zhang L; Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Sun X; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yu Z; Department of Rheumatology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Jia Y; Department of Clinical Immunology, Xi-Jing Hospital, Xi'an, Shaanxi, China.
  • Wang J; Division of Rheumatoid Immunology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Sun W; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Chiu F; Boon Pharmaceutical Research Ltd., 45 Topanga, Irvine, CA, 92602, USA.
  • Pang L; Boon Pharmaceutical Research Ltd., 45 Topanga, Irvine, CA, 92602, USA.
  • Wang G; Department of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China. guochunwang@hotmail.com.
Clin Rheumatol ; 38(2): 617-618, 2019 02.
Article em En | MEDLINE | ID: mdl-30511293

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article